Thermo Fisher Scientific opens sterile drug facility in Singapore to serve Asia-Pacific market

Thermo Fisher Scientific  has opened a new sterile drug facility in Singapore to provide new medicines and vaccines to the Asia-Pacific market.
The new facility was established with assistance from the Singapore Economic Development Board (EDB), in alignment with the government&rsquo;s investment in preparedness for future health emergencies. The current Good Manufacturing Practices (cGMP) center will provide rapid vaccine fill-finish capabilities along with Thermo Fisher&rsquo;s end-to-end pharmaceutical development and manufacturing services.